Literature DB >> 11521928

Treatment of bone-marrow oedema of the talus with the prostacyclin analogue iloprost. An MRI-controlled investigation of a new method.

N Aigner1, G Petje, G Steinboeck, W Schneider, C Krasny, F Landsiedl.   

Abstract

Bone marrow oedema syndrome of the talus is a rare cause of pain in the foot, with limited options for treatment. We reviewed six patients who had been treated with five infusions of 50 microg of iloprost given over six hours on five consecutive days. Full weight-bearing was allowed as tolerated. The foot score as described by Mazur et al was used to assess function before and at one, three and six months after treatment. The mean score improved from 58 to 93 points. Plain radiographs were graded according to the Mont score and showed grade-I lesions before and after treatment, indicating that no subchondral fracture or collapse had occurred. MRI showed complete resolution of the oedema within three months. We conclude that the parenteral administration of iloprost may be used in the treatment of this syndrome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11521928     DOI: 10.1302/0301-620x.83b6.11377

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  25 in total

Review 1.  [Osteonecrosis of the hip in adults].

Authors:  S Hofmann; J Kramer; H Plenk
Journal:  Orthopade       Date:  2005-02       Impact factor: 1.087

2.  When physiology becomes pathology: the role of magnetic resonance imaging in evaluating bone marrow oedema in the humerus in elite tennis players with an upper limb pain syndrome.

Authors:  G Hoy; T Wood; N Phillips; D Connell; D C Hughes
Journal:  Br J Sports Med       Date:  2006-08       Impact factor: 13.800

Review 3.  [Pharmacotherapeutic aspects of femoral head necrosis].

Authors:  I H Tarner; R Dinser; U Müller-Ladner
Journal:  Orthopade       Date:  2007-05       Impact factor: 1.087

4.  Bisphosphonates or prostacyclin in the treatment of bone-marrow oedema syndrome of the knee and foot.

Authors:  Clemens Baier; Jens Schaumburger; Jürgen Götz; Guido Heers; Thorsten Schmidt; Joachim Grifka; Johannes Beckmann
Journal:  Rheumatol Int       Date:  2012-11-10       Impact factor: 2.631

5.  Effects of intravenous iloprost therapy in patients with bone marrow oedema of the foot and ankle.

Authors:  Eric Röhner; Timo Zippelius; David Steindl; Jasmin Fussi; Carsten Perka
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-09-19

6.  Regional migratory osteoporosis: case report of a patient with neuropathic pain.

Authors:  Esin Kartal; Ebru Sahin; Banu Dilek; Meltem Baydar; Metin Manisali; Can Kosay; Selmin Gulbahar
Journal:  Rheumatol Int       Date:  2009-12-12       Impact factor: 2.631

Review 7.  [Pain management in non-juvenile, aseptic osteonecrosis].

Authors:  M Jäger; A Werner; S Lentrodt; U Mödder; R Krauspe
Journal:  Schmerz       Date:  2004-12       Impact factor: 1.107

8.  Outcome of painful bone marrow edema of the femoral head following treatment with parenteral iloprost.

Authors:  Roland Meizer; Dominik Meraner; Elisabeth Meizer; Christian Radda; Franz Landsiedl; Nicolas Aigner
Journal:  Indian J Orthop       Date:  2009-01       Impact factor: 1.251

Review 9.  [Conservative treatment of aseptic necrosis of the femoral head. Are there evidence-based therapy concepts?].

Authors:  C Lüring; J Beckmann; P H Pennekamp; O Linhardt; J Grifka; M Tingart
Journal:  Orthopade       Date:  2007-05       Impact factor: 1.087

Review 10.  Bone marrow edema syndrome.

Authors:  Anastasios V Korompilias; Apostolos H Karantanas; Marios G Lykissas; Alexandros E Beris
Journal:  Skeletal Radiol       Date:  2008-07-16       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.